Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$7.76
-0.12-1.52%
At close: Dec 17, 4:00 PM EST
$7.76
N/A
After Hours: 4:00 PM EST
Comments
Loading...
Journey Medical Analyst Ratings and Price Targets | NASDAQ:DERM | Benzinga
Journey Medical Corp has a consensus price target of $11.08 based on the ratings of 6 analysts. The high is $13 issued by HC Wainwright & Co. on August 25, 2025. The low is $8.5 issued by Alliance Global Partners on February 16, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Lake Street, and B. Riley Securities on August 25, 2025, August 13, 2025, and July 30, 2025, respectively. With an average price target of $12.67 between HC Wainwright & Co., Lake Street, and B. Riley Securities, there's an implied 63.23% upside for Journey Medical Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Lake Street
B. Riley Securities
Rodman & Renshaw
Roth MKM
1calculated from analyst ratings
Analyst Ratings for Journey Medical
FAQ
What is the target price for Journey Medical (DERM) stock?
The latest price target for Journey Medical (NASDAQ:DERM) was reported by HC Wainwright & Co. on August 25, 2025. The analyst firm set a price target for $13.00 expecting DERM to rise to within 12 months (a possible 67.53% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Journey Medical (DERM)?
The latest analyst rating for Journey Medical (NASDAQ:DERM) was provided by HC Wainwright & Co., and Journey Medical initiated their buy rating.
When was the last upgrade for Journey Medical (DERM)?
There is no last upgrade for Journey Medical
When was the last downgrade for Journey Medical (DERM)?
There is no last downgrade for Journey Medical.
When is the next analyst rating going to be posted or updated for Journey Medical (DERM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Journey Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Journey Medical was filed on August 25, 2025 so you should expect the next rating to be made available sometime around August 25, 2026.
Is the Analyst Rating Journey Medical (DERM) correct?
While ratings are subjective and will change, the latest Journey Medical (DERM) rating was a initiated with a price target of $0.00 to $13.00. The current price Journey Medical (DERM) is trading at is $7.76, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
